ALDER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 014339AA3. A total of 30 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,478,000 | +77.7% | 5,895,000 | +82.5% | 0.00% | 0.0% |
| Q1 2019 | $3,083,000 | +330.6% | 3,230,000 | +382.1% | 0.00% | – |
| Q3 2018 | $716,000 | -61.4% | 670,000 | -62.4% | 0.00% | – |
| Q2 2018 | $1,853,000 | -62.0% | 1,784,000 | -66.3% | 0.00% | -100.0% |
| Q1 2018 | $4,871,000 | – | 5,299,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 30,000,000 | $23,930,000 | 3.76% |
| Mohican Financial Management, LLC | 1,000,000 | $800,000 | 3.30% |
| Redmile Group, LLC | 25,000,000 | $19,989,000 | 0.80% |
| SSI INVESTMENT MANAGEMENT LLC | 5,000,000 | $3,989,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,195,000 | $25,943,000 | 0.31% |
| Rock Springs Capital Management LP | 5,000,000 | $4,001,000 | 0.19% |
| City Financial Investment Co Ltd | 1,250,000 | $1,004,000 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,000,000 | $3,221,000 | 0.12% |
| CSS LLC/IL | 2,000,000 | $1,606,000 | 0.11% |
| DAFNA Capital Management LLC | 250,000 | $201,000 | 0.10% |